We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$102B
AUM Growth
+$52.8B
Cap. Flow
+$49.1B
Cap. Flow %
47.94%
Top 10 Hldgs %
15.17%
Holding
1,714
New
159
Increased
1,288
Reduced
80
Closed
149

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$836M
2
CAH icon
Cardinal Health
CAH
+$796M
3
BNY
Bank of New York Mellon
BNY
+$766M
4
INTC icon
Intel
INTC
+$763M
5
VZ icon
Verizon
VZ
+$761M

Sector Composition

Rank Sector Weight
1 Healthcare 16.98%
2 Financials 13.97%
3 Industrials 10.97%
4 Technology 10.76%
5 Energy 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCB icon
1126
Ameris Bancorp
ABCB
$5.9B
$1.93M ﹤0.01%
65,108
-70,680
-52% -$2.16M
SUI icon
1127
Sun Communities
SUI
$15B
$1.92M ﹤0.01%
25,000
+14,600
+140% +$1.03M
DO
1128
DELISTED
Diamond Offshore Drilling
DO
$1.9M ﹤0.01%
+78,200
New +$1.86M
COTV
1129
DELISTED
Cotiviti Holdings, Inc.
COTV
$1.9M ﹤0.01%
+89,964
New +$1.71M
CHRS icon
1130
Coherus Oncology
CHRS
$217M
$1.88M ﹤0.01%
+111,110
New +$2.09M
KR icon
1131
Kroger
KR
$34.8B
$1.88M ﹤0.01%
51,000
-120,400
-70% -$4.33M
TRN icon
1132
Trinity Industries
TRN
$2.97B
$1.87M ﹤0.01%
140,011
+70,005
+100% +$926K
TDOC icon
1133
Teladoc Health
TDOC
$1.58B
$1.86M ﹤0.01%
+116,200
New +$1.36M
CALM icon
1134
Cal-Maine
CALM
$4.28B
$1.85M ﹤0.01%
41,800
+9,000
+27% +$424K
CHS
1135
DELISTED
Chicos FAS, Inc.
CHS
$1.85M ﹤0.01%
+172,720
New +$2.02M
ITCI
1136
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.83M ﹤0.01%
+47,200
New +$1.7M
STGW icon
1137
Stagwell
STGW
$1.84B
$1.83M ﹤0.01%
+100,000
New +$1.93M
NTT
1138
DELISTED
Nippon Telegraph & Telephone
NTT
$1.83M ﹤0.01%
38,818
+12,910
+50% +$574K
SEIC icon
1139
SEI Investments
SEIC
$11.9B
$1.82M ﹤0.01%
37,920
-17,886
-32% -$861K
CRTO icon
1140
Criteo
CRTO
$1.03B
$1.8M ﹤0.01%
+39,200
New +$1.69M
GATX icon
1141
GATX Corp
GATX
$6.55B
$1.79M ﹤0.01%
40,800
+20,400
+100% +$935K
RLJ icon
1142
RLJ Lodging Trust
RLJ
$1.87B
$1.79M ﹤0.01%
83,500
+44,350
+113% +$944K
NVCR icon
1143
NovoCure
NVCR
$2.04B
$1.77M ﹤0.01%
+151,294
New +$1.89M
EBF icon
1144
Ennis
EBF
$546M
$1.76M ﹤0.01%
91,600
+45,800
+100% +$869K
AGO icon
1145
Assured Guaranty
AGO
$3.78B
$1.75M ﹤0.01%
68,800
+34,400
+100% +$886K
PCAR icon
1146
PACCAR
PCAR
$69.6B
$1.73M ﹤0.01%
50,100
+35,100
+234% +$1.29M
MNTA
1147
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.73M ﹤0.01%
160,000
+80,000
+100% +$825K
ALK icon
1148
Alaska Air
ALK
$5.15B
$1.73M ﹤0.01%
29,600
+14,800
+100% +$1.02M
SCOR icon
1149
Comscore
SCOR
$110M
$1.73M ﹤0.01%
3,615
+2,025
+127% +$1.21M
KAMN
1150
DELISTED
Kaman Corp
KAMN
$1.73M ﹤0.01%
40,600
+12,500
+44% +$526K

Similar funds

Macquarie Group's Q2 2016 Portfolio in Review

As of Q2 2016, Macquarie Group held 1,714 positions worth $102B, up 106% from $49.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group deployed $49.1B of net new capital in Q2 2016, opening 159 new positions and adding to 1,288 existing holdings. Its largest new stake was iShares Russell 2000 Value ETF: 1,161,694 shares worth $113M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was BAXALTA INC COM STK (DE), an estimated $737M trimmed.

  • Macquarie Group's largest Q2 2016 buy was iShares Russell 2000 Value ETF: 1,161,694 shares worth $113M.
  • Macquarie Group added most to CVS Health in Q2 2016, an estimated $836M increase.
  • Macquarie Group's biggest Q2 2016 reduction was BAXALTA INC COM STK (DE), cutting an estimated $737M.
  • Macquarie Group fully exited Bausch Health in Q2 2016, selling an estimated $71M.
  • Macquarie Group's ten largest holdings make up 15% of its $102B portfolio in Q2 2016.
  • Macquarie Group opened 159 new positions and closed 149 in Q2 2016.
  • Macquarie Group's portfolio value rose 106% quarter-over-quarter to $102B.

Based on Macquarie Group's 13F filing for Q2 2016, filed 15 Aug 2016.